Gallstone dissolution treatment with a combination of chenodeoxycholic and ursodeoxycholic acids
β Scribed by Richard Roehrkasse; Hans Fromm; Mauro Malavolti; Anand K. Tunuguntla; Susan Ceryak
- Book ID
- 112510072
- Publisher
- Springer US
- Year
- 1986
- Tongue
- English
- Weight
- 716 KB
- Volume
- 31
- Category
- Article
- ISSN
- 0163-2116
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The Sunnybrook Gallstone Study was a randomized, double-blind, controlled trial of chenodeoxycholic acid treatment over 2 years in 160 patients with radiolucent gallstones. Sixty-four patients received 750 mg daily, 5 3 received 375 mg daily and 43 received placebo. Total dissolution of gallstones o
A double-blind randomized, multicenter study was carried out to determine the efficacy and safety of ursodeoxycholic acid (UDCA) at 4 doses of 2.1 to 16.2 mg.kg-'.day-', and chenodeoxycholic acid (CDCA) at the dose of 16.9 mg. kg-' .day-', in 197 patients treated for up to 1 year for radiolucent gal
The objective of this study was to investigate cholesterol metabolism in human gallbladder mucosa, especially in relation to hepatic cholesterol metabolism, gallstone disease and treatment with bile acids. Gallbladder mucosa and liver tissue samples were collected in 44 patients undergoing cholecyst